The global laboratory information management system (LIMS) market was valued at approximately USD 2.3 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 6.48% from 2024 to 2030. This anticipated growth is largely driven by significant technological advancements in pharmaceutical laboratories, along with an increasing demand for lab automation. As research and development (R&D) labs—particularly in the pharmaceutical and biotechnological sectors—continue to evolve, they are expected to contribute positively to the overall industry growth.
Moreover, the appeal of LIMS is bolstered by factors such as the low cost of implementation, efficient time management capabilities, and strict compliance with Good Distribution Practice (GDP), Good Clinical Practice (GCP), and Good Manufacturing Practice (GMP) regulations. These aspects are crucial for organizations aiming to enhance their operational efficiency while adhering to industry standards.
Gather more insights about the market drivers, restrains and growth of the Laboratory Information Management System Market
Component Segmentation Insights
The LIMS market can be categorized into two primary components: software and services. The services segment dominated the LIMS market, accounting for over 58% of the global revenue in 2023. This dominance is attributed to the growing need for LIMS implementation, integration, maintenance, validation, and ongoing support. As laboratories increasingly seek specialized expertise for these tasks, the demand for LIMS outsourcing solutions is also expected to escalate.
In many large pharmaceutical research laboratories, there is often a noticeable shortage of the necessary resources and skills required for the effective deployment of analytics solutions. As a result, these services are frequently outsourced, with arrangements that can be short-term, project-based, or established through long-term contracts. The outsourced services typically come in comprehensive packages that may include compliance monitoring for promotional spending, social media analytics, predictive analytics for potential medical device failures, benchmarking services, and various other analytical offerings.
On the other hand, the software segment is anticipated to experience steady growth throughout the forecast period, spurred by advancements from traditional Software as a Service (SaaS) to more sophisticated models like Platform as a Service (PaaS), Container as a Service (CaaS), and community network solutions. Numerous market players are actively adopting diverse strategies to promote growth within this segment. For instance, in May 2021, LabVantage Solutions introduced an innovative analytics solution alongside a certified SaaS offering and an updated version of its LIMS Platform, showcasing the ongoing evolution and enhancement of software capabilities in the market.
Overall, the interplay between software advancements and service requirements is expected to shape the LIMS landscape significantly, as laboratories strive for improved efficiency, compliance, and adaptability in an increasingly complex regulatory environment.
Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.
